Nontuberculosis mycobacterium (NTM) infections often result in a chronic, debilitating pulmonary disease. Diagnosis and recognition of NTM infections is increasing, yet research and evidence are lacking and more is needed to provide optimized counseling and informed decisions surrounding interventions. More information is needed about detailed clinical and demographic predictors for impaired health-related quality of life among patients with NTM pulmonary infections.
